View in EDS

α-Ketoglutarate dehydrogenase is a therapeutic vulnerability in acute myeloid leukemia.

Saved in:
Bibliographic Details
Title: α-Ketoglutarate dehydrogenase is a therapeutic vulnerability in acute myeloid leukemia.
Authors: Millman SE; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY., Chaves-Perez A; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY., Janaki-Raman S; Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, NY., Ho YJ; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY., Morris JP 4th; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY., Narendra V; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY., Chen CC; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY., Jackson BT; Cell Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY., Yashinskie JJ; Cell Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY., Mezzadra R; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY., Devine TI; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY., Barthet VJA; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY., Saoi M; Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, NY., Baslan T; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY., Tian S; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY., Sachs Z; Division of Hematology, Oncology, and Transplantation, Department of Medicine and Masonic Cancer Center, University of Minnesota, Minneapolis, MN., Finley LWS; Cell Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY., Cross JR; Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, NY., Lowe SW; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY.; Howard Hughes Medical Institute, Chevy Chase, MD.
Source: Blood [Blood] 2025 Mar 27; Vol. 145 (13), pp. 1422-1436.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1528-0020
DOI:10.1182/blood.2024025245